Nutraceutical approach for preventing obesity-related colorectal and liver carcinogenesis.
about
Carboxylesterase-2 is a highly sensitive target of the antiobesity agent orlistat with profound implications in the activation of anticancer prodrugs.Inhibitory effects of astaxanthin on azoxymethane-induced colonic preneoplastic lesions in C57/BL/KsJ-db/db mice.Chemopreventive potential of green tea catechins in hepatocellular carcinoma.Metformin suppresses diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BL/KsJ-+Leprdb/+Leprdb mice.Enhanced development of azoxymethane-induced colonic preneoplastic lesions in hypertensive rats.Branched-chain amino acids suppress the cumulative recurrence of hepatocellular carcinoma under conditions of insulin-resistanceDifferent Susceptibilities between Apoe- and Ldlr-Deficient Mice to Inflammation-Associated Colorectal Carcinogenesis.Treatment of obesity with the resveratrol-enriched rice DJ-526Interaction between hepatitis C virus and metabolic factors.Obesity and hepatocellular carcinoma: targeting obesity-related inflammation for chemoprevention of liver carcinogenesis.Clinical significance of therapy using branched-chain amino acid granules in patients with liver cirrhosis and hepatocellular carcinoma.Pharmaceutical and nutraceutical approaches for preventing liver carcinogenesis: chemoprevention of hepatocellular carcinoma using acyclic retinoid and branched-chain amino acids.Green tea and anticancer perspectives: updates from last decade.Bioavailable insulin-like growth factor-I as mediator of racial disparity in obesity-relevant breast and colorectal cancer risk among postmenopausal women.Preventive effects of the angiotensin-converting enzyme inhibitor, captopril, on the development of azoxymethane-induced colonic preneoplastic lesions in diabetic and hypertensive rats.(-)-Epigallocatechin-3-gallate suppresses hepatic preneoplastic lesions developed in a novel rat model of non-alcoholic steatohepatitisSodium alginate prevents progression of non-alcoholic steatohepatitis and liver carcinogenesis in obese and diabetic mice.Preventive Effects of Pentoxifylline on the Development of Colonic Premalignant Lesions in Obese and Diabetic MicePreventive effects of astaxanthin on diethylnitrosamine-induced liver tumorigenesis in C57/BL/KsJ-db/db obese mice.Preventive effects of branched-chain amino acid supplementation on the spontaneous development of hepatic preneoplastic lesions in C57BL/KsJ-db/db obese mice.The impact of meal composition on the release of fatty acids from salmon during in vitro gastrointestinal digestion.
P2860
Q33916086-793CE92C-9DB5-4D9D-8A38-B43A9B18EA06Q34754173-576C85E3-42E3-4D77-B306-B5F67BFBAB39Q35381561-2AC1AF7D-773C-40D7-A017-D478F9FBB761Q35447135-62EC2ED8-D048-42F3-91DD-45FF9D5803F6Q37092009-79A30BAC-2F13-4F54-814A-9670DB16A9B4Q37276989-A96A8FF0-A6C1-4E13-BDA6-ED1EA76362F8Q37465413-730BB89C-B549-419B-82C4-0495C3223542Q37517007-3443C2B5-0CA6-4887-B162-8797502BCD9BQ37654443-368CBC31-8860-4A9B-AB1F-F157933DB9C5Q38040323-A9BBFACB-49D9-4844-B93A-7CF4BBC791D1Q38118780-BED34410-E808-4EBE-B11D-2F155D62E5D7Q38165918-537D5CDB-C468-400D-BD08-2294C70C001BQ38219139-60F5283D-57A3-4D6C-95E8-ABE7765F9E69Q40538058-453CC3FD-C36C-48C6-9D92-601F838DE17DQ40892149-EA8EFC85-BB9E-4889-944E-10ED4136B4F1Q41446435-4D2A3744-BD61-4821-821C-78356E921C99Q42087544-8D3DC44C-E595-4F1E-9274-C6719BE8FFEEQ42317350-4A27EF9D-7A6B-49A6-9FE7-D80C56937BC7Q42479379-4234EE5D-3EF8-48A7-8948-ABE738D67C56Q42513537-5EB8954C-290F-4161-A428-F1E42672FBA0Q45912453-766A29FF-D9E9-4D95-9CBB-A9FABFD1DC08
P2860
Nutraceutical approach for preventing obesity-related colorectal and liver carcinogenesis.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Nutraceutical approach for pre ...... ctal and liver carcinogenesis.
@ast
Nutraceutical approach for pre ...... ctal and liver carcinogenesis.
@en
Nutraceutical approach for pre ...... ctal and liver carcinogenesis.
@nl
type
label
Nutraceutical approach for pre ...... ctal and liver carcinogenesis.
@ast
Nutraceutical approach for pre ...... ctal and liver carcinogenesis.
@en
Nutraceutical approach for pre ...... ctal and liver carcinogenesis.
@nl
prefLabel
Nutraceutical approach for pre ...... ctal and liver carcinogenesis.
@ast
Nutraceutical approach for pre ...... ctal and liver carcinogenesis.
@en
Nutraceutical approach for pre ...... ctal and liver carcinogenesis.
@nl
P2093
P2860
P356
P1476
Nutraceutical approach for pre ...... ctal and liver carcinogenesis.
@en
P2093
Hisataka Moriwaki
Masahito Shimizu
Masaya Kubota
Takuji Tanaka
P2860
P304
P356
10.3390/IJMS13010579
P407
P5008
P577
2012-01-05T00:00:00Z